PNV 4.96% $2.54 polynovo limited

Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-39

  1. 546 Posts.
    lightbulb Created with Sketch. 131
    I'm delighted that I'm able to invest in a company that's developing this kind of hugely beneficial medical tech (as well as making healthy gains!). My dad suffered from diabetic foot ulcers in the 90s and ended up, after some years of battling them to no avail, having to have both legs amputated below the knee as a direct result. Power to Polynovo for developing products that can make such a huge positive impact on people's quality of life.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.54
Change
0.120(4.96%)
Mkt cap ! $1.754B
Open High Low Value Volume
$2.50 $2.54 $2.43 $4.835M 1.931M

Buyers (Bids)

No. Vol. Price($)
30 81780 $2.52
 

Sellers (Offers)

Price($) Vol. No.
$2.54 5610 4
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.